tiprankstipranks
Trending News
More News >
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market

Avecho Biotechnology Limited (AVE) Income Statement

Compare
9 Followers

Avecho Biotechnology Limited Income Statement

Last quarter (Q4 2025), Avecho Biotechnology Limited's total revenue was AU$957.73K, an increase of 3432.48% from the same quarter last year. In Q4, Avecho Biotechnology Limited's net income was AU$-3.08M. See Avecho Biotechnology Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 1.24MAU$ 1.13MAU$ 473.55KAU$ 1.13MAU$ 793.60K
Gross Profit
AU$ 751.29KAU$ 671.93KAU$ -43.80KAU$ 793.12KAU$ 507.94K
Operating Expenses
AU$ 6.76MAU$ 5.63MAU$ 4.55MAU$ 3.86MAU$ 5.06M
Depreciation and Amortization
AU$ 137.09KAU$ 144.88KAU$ 178.69KAU$ 230.35KAU$ 428.59K
EBITDA
AU$ -5.87MAU$ -2.92MAU$ -3.24MAU$ -2.11MAU$ -2.98M
Operating Income
AU$ -6.00MAU$ -4.96MAU$ -4.59MAU$ -3.06MAU$ -4.55M
Other Income/Expenses
AU$ -408.21KAU$ 1.84MAU$ 77.06KAU$ 98.55KAU$ 1.13M
Pretax Income
AU$ -6.41MAU$ -3.12MAU$ -4.51MAU$ -2.96MAU$ -4.54M
Net Income
AU$ -4.42MAU$ -3.12MAU$ -3.44MAU$ -2.34MAU$ -3.42M
Per Share Metrics
Basic EPS
AU$ >-0.01AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Diluted EPS
AU$ >-0.01AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Weighted Average Shares Outstanding
3.27B 3.12B 2.27B 1.80B 1.80B
Weighted Average Shares Outstanding (Diluted)
3.27B 3.12B 2.27B 1.84B 1.80B
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History